SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    J. R. Deuis, Y. L. Lim, S. Rodrigues de Sousa, R. J. Lewis, P. F. Alewood, P. J. Cabot, I. Vetter, Analgesic effects of clinically used compounds in novel mouse models of polyneuropathy induced by oxaliplatin and cisplatin, Neuro-Oncology, 2014, 16, 10, 1324

    CrossRef

  2. 2
    Ryan Patel, Leonor Gonçalves, Mathew Leveridge, Stephen R. Mack, Alan Hendrick, Nicola L. Brice, Anthony H. Dickenson, Anti-hyperalgesic effects of a novel TRPM8 agonist in neuropathic rats: A comparison with topical menthol, PAIN®, 2014, 155, 10, 2097

    CrossRef

  3. 3
    Mehdi Saad, Camille Tafani, Dimitri Psimaras, Damien Ricard, Chemotherapy-induced peripheral neuropathy in the adult, Current Opinion in Oncology, 2014, 26, 6, 634

    CrossRef

  4. 4
    Guido Cavaletti, Chemotherapy-induced peripheral neurotoxicity (CIPN): what we need and what we know, Journal of the Peripheral Nervous System, 2014, 19, 2
  5. 5
    Ahmed H. Zedan, Ole J. Vilholm, Chemotherapy-Induced Polyneuropathy: Major Agents and Assessment by Questionnaires, Basic & Clinical Pharmacology & Toxicology, 2014, 115, 2
  6. 6
    R. Velasco, J. Bruna, C. Briani, A. A. Argyriou, G. Cavaletti, P. Alberti, B. Frigeni, M. Cacciavillani, S. Lonardi, D. Cortinovis, M. Cazzaniga, C. Santos, H. P. Kalofonos, Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients, Journal of Neurology, Neurosurgery & Psychiatry, 2014, 85, 4, 392

    CrossRef

  7. 7
    Tomohisa Mori, Tomoe Kanbara, Masato Harumiya, Yoshiyuki Iwase, Aki Masumoto, Sachiko Komiya, Atsushi Nakamura, Masahiro Shibasaki, Toshiyuki Kanemasa, Gaku Sakaguchi, Tsutomu Suzuki, Establishment of Opioid-Induced Rewarding Effects Under Oxaliplatin- and Paclitaxel-Induced Neuropathy in Rats, Journal of Pharmacological Sciences, 2014, 126, 1, 47

    CrossRef

  8. 8
    Gary J. Bennett, Timothy Doyle, Daniela Salvemini, Mitotoxicity in distal symmetrical sensory peripheral neuropathies, Nature Reviews Neurology, 2014, 10, 6, 326

    CrossRef

  9. 9
    Desiree Jones, Fengmin Zhao, Joanna Brell, Mark A. Lewis, Charles L. Loprinzi, Matthias Weiss, Michael J. Fisch, Neuropathic symptoms, quality of life, and clinician perception of patient care in medical oncology outpatients with colorectal, breast, lung, and prostate cancer, Journal of Cancer Survivorship, 2014,

    CrossRef

  10. 10
    María Sereno, Gerardo Gutiérrez-Gutiérrez, César Gómez-Raposo, Miriam López-Gómez, Maria Merino-Salvador, Francisco Zambrana Tébar, Cristina Rodriguez-Antona, Enrique Casado, Oxaliplatin induced-neuropathy in digestive tumors, Critical Reviews in Oncology/Hematology, 2014, 89, 1, 166

    CrossRef

  11. 11
    Roser Velasco, Jordi Bruna, Oxaliplatin Neurotoxicity, Current Colorectal Cancer Reports, 2014, 10, 3, 303

    CrossRef

  12. 12
    A. Custodio, J. Moreno-Rubio, J. Aparicio, J. Gallego-Plazas, R. Yaya, J. Maurel, O. Higuera, E. Burgos, D. Ramos, A. Calatrava, E. Andrada, R. Lopez, V. Moreno, R. Madero, P. Cejas, J. Feliu, Pharmacogenetic predictors of severe peripheral neuropathy in colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy: a GEMCAD group study, Annals of Oncology, 2014, 25, 2, 398

    CrossRef

  13. 13
    R. Velasco, S. Videla, J. Villoria, E. Ortiz, X. Navarro, J. Bruna, Reliability and accuracy of quantitative sensory testing for oxaliplatin-induced neurotoxicity, Acta Neurologica Scandinavica, 2014, 130, 6
  14. 14
    Tomoe Kanbara, Atsushi Nakamura, Keiko Takasu, Koichi Ogawa, Masahiro Shibasaki, Tomohisa Mori, Tsutomu Suzuki, Minoru Hasegawa, Gaku Sakaguchi, Toshiyuki Kanemasa, The Contribution of Gi/o Protein to Opioid Antinociception in an Oxaliplatin-Induced Neuropathy Rat Model, Journal of Pharmacological Sciences, 2014,

    CrossRef

  15. You have free access to this content15
    Susanna B. Park, David Goldstein, Arun V. Krishnan, Cindy S-Y Lin, Michael L. Friedlander, James Cassidy, Martin Koltzenburg, Matthew C. Kiernan, Chemotherapy-induced peripheral neurotoxicity: A critical analysis, CA: A Cancer Journal for Clinicians, 2013, 63, 6
  16. 16
    Marta Campagnolo, Daniela Lazzarini, Iva Fregona, Mario Cacciavillani, Francesca Bergamo, Raffaele Parrozzani, Edoardo Midena, Chiara Briani, Corneal confocal microscopy in patients with oxaliplatin-induced peripheral neuropathy, Journal of the Peripheral Nervous System, 2013, 18, 3
  17. 17
    D. Cortinovis, P. Alberti, B. Frigeni, P. Bidoli, G. Cavaletti, Neuroprotectant agents against oxaliplatin induced neurotoxicity: lackings, facts and future prospective, Annals of Oncology, 2013, 24, 5, 1418

    CrossRef

  18. 18
    Cindy Tofthagen, Kristine A. Donovan, Mary Ann Morgan, David Shibata, Yating Yeh, Oxaliplatin-induced peripheral neuropathy’s effects on health-related quality of life of colorectal cancer survivors, Supportive Care in Cancer, 2013, 21, 12, 3307

    CrossRef

  19. 19
    Manuel Diezi, Thierry Buclin, Thierry Kuntzer, Toxic and drug-induced peripheral neuropathies, Current Opinion in Neurology, 2013, 26, 5, 481

    CrossRef

  20. 20
    Andreas A. Argyriou, Guido Cavaletti, Anna Antonacopoulou, Armando A. Genazzani, Chiara Briani, Jordi Bruna, Salvatore Terrazzino, Roser Velasco, Paola Alberti, Marta Campagnolo, Sara Lonardi, Diego Cortinovis, Marina Cazzaniga, Cristina Santos, Aikaterini Psaromyalou, Aikaterini Angelopoulou, Haralabos P. Kalofonos, Voltage-gated sodium channel polymorphisms play a pivotal role in the development of oxaliplatin-induced peripheral neurotoxicity: Results from a prospective multicenter study, Cancer, 2013, 119, 19